Letter by Mansour et al Regarding Article, "Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-Acetylcysteine in Acute Myocardial Infarction])"

Alexandre Mansour (1) , Hervé Le Breton (2, 3) , Vincent Auffret (2, 3)

1 CHU Pontchaillou [Rennes]
2 Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes]
3 LTSI - Laboratoire Traitement du Signal et de l'Image

Domains: Life Sciences [q-bio]; Bioengineering

Alexandre Mansour, Hervé Le Breton, Vincent Auffret. Letter by Mansour et al Regarding Article, "Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-Acetylcysteine in Acute Myocardial Infarction])". Circulation, 2018, 137 (13), pp.1420-1421. ⟨10.1161/CIRCULATIONAHA.117.030180⟩. ⟨hal-01769632⟩